Generics gain indications for glycemic control, reducing heart failure hospitalization ...

I have been a clinical researcher for almost 50 years. After medical school and internal medicine residency, I was selected to go to the National Institutes of Health where I learned the basics of ...

Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with ...

The Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 represents a revived effort from the 118th Congress.

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Axelpharm, the Russian manufacturer of anticancer generics, may suspend operations due to fines from the local antitrust ...

Manufacturers of generic and biosimilar medicines should rethink their real world launch, lifecycle and litigation strategies ...

ANIP eyes 2026 growth via Cortrophin's gout push and steady generics launches, as Rare Disease expansion reshapes priorities and investor focus.